By Connor Boyd Health Reporter For Mailonline
Published: 15:34 BST, 18 October 2019 | Updated: 15:36 BST, 18 October 2019
An Ebola vaccine has been approved by European drugs regulators in a move hailed as a 'triumph for public health'.
The so-called Merk vaccine was green lit this afternoon and is likely to get a full marketing licence from the European Commission within a few weeks.
It is already being used under emergency guidelines to try to halt the deadly outbreak currently ravaging the Democratic Republic of Congo.
The vaccine, developed by US drugmaker Merck & Co, is also being reviewed under a fast-track system by regulators in America.
An Ebola vaccine has been approved by European drugs regulators on Friday in what is being hailed as a 'triumph for public health' (file)
The World Health Organization (WHO) said the advancement was a 'triumph for public